Medicina

2013

1. 2013 ESC guidelines on the management of stable coronary artery disease

   European Heart Journal, Vol. 34, Núm. 38, pp. 2949-3003

2. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

   European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219

3. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

   Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755

4. 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

   Arthritis and Rheumatism, Vol. 65, Núm. 11, pp. 2737-2747

5. 213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

   European Heart Journal, Vol. 34, Núm. 29, pp. 2281-2329

6. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

   Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 11, pp. 1870-1876

7. 3D color-Doppler echocardiography and chronic aortic regurgitation: A novel approach for severity assessment

   International Journal of Cardiology, Vol. 166, Núm. 3, pp. 640-645

8. A case of rhino-orbito-cerebral mucormycosis in a non-diabetic HIV patient with metabollic acidosis

   HIV and AIDS Review, Vol. 12, Núm. 3, pp. 73-75

9. A comprehensive, national survey of spirometry in Spain: Current bottlenecks and future directions in primary and secondary care

   Chest, Vol. 144, Núm. 2, pp. 601-609

10. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

11. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

    Leukemia, Vol. 27, Núm. 10, pp. 2056-2061

12. A new approach to grading and treating COPD based on clinical phenotypes: Summary of the Spanish COPD guidelines (GesEPOC)

    Primary Care Respiratory Journal, Vol. 22, Núm. 1, pp. 117-121

13. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

    Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61

14. A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

    European Journal of Cancer, Vol. 49, Núm. 18, pp. 3763-3772

15. A profibrotic role for thymic stromal lymphopoietin in Systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2018-2029

16. A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer

    Journal of Thoracic Oncology, Vol. 8, Núm. 3, pp. 329-337

17. A randomized phase II non-comparative study of pemetrexed carboplatin and gemcitabine vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

    International Journal of Oncology, Vol. 42, Núm. 5, pp. 1778-1785

18. A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

    Annals of Oncology, Vol. 24, Núm. 7, pp. 1777-1785

19. A research agenda on the management of intra-abdominal candidiasis: Results from a consensus of multinational experts

    Intensive Care Medicine, Vol. 39, Núm. 12, pp. 2092-2106

20. A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis

    Neuroepidemiology, Vol. 40, Núm. 3, pp. 147-153